JP2023518390A5 - - Google Patents
Info
- Publication number
- JP2023518390A5 JP2023518390A5 JP2022555887A JP2022555887A JP2023518390A5 JP 2023518390 A5 JP2023518390 A5 JP 2023518390A5 JP 2022555887 A JP2022555887 A JP 2022555887A JP 2022555887 A JP2022555887 A JP 2022555887A JP 2023518390 A5 JP2023518390 A5 JP 2023518390A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- viral infection
- approximately
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062990168P | 2020-03-16 | 2020-03-16 | |
| US62/990,168 | 2020-03-16 | ||
| PCT/US2021/022538 WO2021188520A1 (en) | 2020-03-16 | 2021-03-16 | Method and compositions for treating, preventing or limiting the occurrence of viral infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518390A JP2023518390A (ja) | 2023-05-01 |
| JP2023518390A5 true JP2023518390A5 (https=) | 2024-03-27 |
Family
ID=77768366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555887A Pending JP2023518390A (ja) | 2020-03-16 | 2021-03-16 | ウイルス感染症の治療若しくは予防又はウイルス感染症の発生を制限するための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230132782A1 (https=) |
| EP (1) | EP4121040A4 (https=) |
| JP (1) | JP2023518390A (https=) |
| KR (1) | KR20230012469A (https=) |
| CN (1) | CN115397410A (https=) |
| AU (1) | AU2021236622A1 (https=) |
| BR (1) | BR112022018504A2 (https=) |
| CA (1) | CA3172162A1 (https=) |
| WO (1) | WO2021188520A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230165831A1 (en) * | 2021-11-19 | 2023-06-01 | Impact Biolife Science, Inc. | Method and composition for rendering cancer cells susceptible to treatment by targeted oncogenetic drivers |
| CN117462539A (zh) * | 2023-12-26 | 2024-01-30 | 云南中医药大学 | 一种二氢黄酮醇型化合物的抗冠状病毒用途及制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1605335A (zh) * | 2003-05-30 | 2005-04-13 | 任启生 | 含有二氢杨梅素和杨梅素的组合物用于抗病毒等药物 |
| US8034838B2 (en) * | 2008-05-29 | 2011-10-11 | Daryl Lee Thompson | Composition and method for the treatment of neurological disorders |
| CN101701245B (zh) * | 2009-10-21 | 2013-06-19 | 中国科学院生物物理研究所 | 从中药中筛选sars冠状病毒主蛋白酶抑制剂的方法 |
| US20140194500A1 (en) * | 2013-01-08 | 2014-07-10 | Kookmin University Industry Academic Cooperation Foundation | Methods For Treating of SARS |
| US10383842B2 (en) * | 2015-02-13 | 2019-08-20 | Global Biolife Inc. | Method and composition for preventing and treating viral infections |
| US12257231B2 (en) * | 2015-02-13 | 2025-03-25 | Global Biolife Inc. | Method and composition for preventing and treating viral infections |
| US10123991B2 (en) * | 2015-05-15 | 2018-11-13 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
| US10966954B2 (en) * | 2016-05-16 | 2021-04-06 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
| US10987371B2 (en) * | 2017-06-09 | 2021-04-27 | Adaerata, Limited Partnership | Methods of preventing or treating filovirus and flavivirus diseases |
| WO2019045677A1 (en) * | 2017-08-28 | 2019-03-07 | Global Biolife Inc. | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS |
| CN113350330B (zh) * | 2020-03-06 | 2023-04-14 | 中国科学院上海药物研究所 | 杨梅素类化合物在制备防治新冠肺炎药物中的应用 |
| CN112546038A (zh) * | 2020-11-19 | 2021-03-26 | 澳门科技大学 | 杨梅素在制备预防或治疗冠状病毒、流感病毒的药物中的应用 |
| CN113244217A (zh) * | 2021-06-25 | 2021-08-13 | 南开大学 | 二氢杨梅素在制备抑制新冠病毒或肺部纤维化的药物中的应用 |
-
2021
- 2021-03-16 BR BR112022018504A patent/BR112022018504A2/pt not_active Application Discontinuation
- 2021-03-16 AU AU2021236622A patent/AU2021236622A1/en active Pending
- 2021-03-16 KR KR1020227035956A patent/KR20230012469A/ko not_active Ceased
- 2021-03-16 JP JP2022555887A patent/JP2023518390A/ja active Pending
- 2021-03-16 WO PCT/US2021/022538 patent/WO2021188520A1/en not_active Ceased
- 2021-03-16 CN CN202180025427.5A patent/CN115397410A/zh active Pending
- 2021-03-16 CA CA3172162A patent/CA3172162A1/en active Pending
- 2021-03-16 US US17/911,455 patent/US20230132782A1/en not_active Abandoned
- 2021-03-16 EP EP21771167.0A patent/EP4121040A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Quenelle et al. | In vitro and in vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections | |
| MA57933B1 (fr) | Composés hautement actifs contre la covid-19 | |
| JP2023518390A5 (https=) | ||
| US9683268B2 (en) | Viruses associated with immunodeficiency and enteropathy and methods using same | |
| JP2010510967A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP6741747B2 (ja) | Ｃ型肝炎ウイルスポリメラーゼの阻害剤 | |
| CN105363034A (zh) | 治疗流感的联合疗法 | |
| JP2013544788A (ja) | ポリメラーゼの阻害のための方法および組成物 | |
| EA022303B1 (ru) | Комбинации ингибиторов вируса гепатита с | |
| CA2599348A1 (en) | Indole compound and use thereof | |
| JP2007197470A5 (https=) | ||
| JP2012532872A5 (https=) | ||
| WO2012103113A1 (en) | Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c | |
| JPWO2023054292A5 (https=) | ||
| Zhou et al. | Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses | |
| WO2021217053A1 (en) | Plasma kallikrein inhibitors for the treatment of ards and related conditions | |
| JP2005521664A5 (https=) | ||
| KR101097189B1 (ko) | 디히드록시크로몬 유도체를 유효성분으로 함유하는 코로나바이러스로 인해 유발되는 질환의 치료 및 예방을 위한 약학 조성물 | |
| WO2023285654A2 (en) | Compounds for the treatment of covid-19 | |
| JP2013506703A5 (https=) | ||
| CN105085455A (zh) | 唾液酸类似物或其药学上可接受的盐及其应用 | |
| JP2023518390A (ja) | ウイルス感染症の治療若しくは予防又はウイルス感染症の発生を制限するための方法及び組成物 | |
| JP2023518249A5 (https=) | ||
| CA2514373A1 (en) | N-phenylbenzamide derivatives as drugs for the treatment of copd |